COMMON NAME |
MLN-1202, MLN1202, anti-CCR2, hu1D9 |
---|---|
SYNONYMS |
CC-CKR-2;CCR2A;CCR2B;CD192;CKR2;CKR2A;CKR2B;CMKBR2;MCP-1-R |
APPLICATIONS |
Flow Cyt |
RECOMMENDED DILUTIONS |
Flow Cyt 1:100 |
FORMULATION & RECONSTITUTION |
Lyophilized from sterile PBS, pH 7.4. Normally 5 % – 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions of reconstitution. |
HOST SPECIES |
Humanized |
IGG TYPE |
IgG1 |
REACTIVITY |
Human |
TARGET | |
UNIPROT ID |
P41597 |
DESCRIPTION |
Anti-CCR2(plozalizumab biosimilar) mAb |
DELIVERY |
In Stock |
STORAGE & SHIPPING |
Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature. |
BACKGROUND |
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals. |
USAGE |
Research use only |
SKU(재고 관리 코드):BME100087
Anti-CCR2(plozalizumab biosimilar) mAb
Anti-CCR2(plozalizumab biosimilar) mAb
PRODUCT DATA
IMAGES
Figure 1. Flow cytometry analysis with 1 μg/mL Anti-CCR2 (plozalizumab biosimilar) mAb (BME100087) on Expi293 cells transfected with Human CCR2 protein (Blue histogram) or Expi293 transfected with irrelevant protein (Red histogram).